Karen L Rascati,
Adjunct Full Instructional Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6268
Business Email:
krascati@ufl.edu
Teaching Profile
Courses Taught
2012-2024
PHA6283 Introduction to Pharmacoeconomics
2013
PHA6287 Pharmaceutical Health Economics
2021-2024
PHA6935 Selected Topics in Pharmacy
Publications
2022
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia: A Propensity Score Matched National-Level Study.
Alzheimer disease and associated disorders.
36(3):244-252
[DOI] 10.1097/WAD.0000000000000504.
[PMID] 35293380.
2022
Healthcare Fraud Data Mining Methods: A Look Back and Look Ahead.
Perspectives in health information management.
19(1)
[PMID] 35440932.
2021
Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?
Health literacy research and practice.
5(3):e171-e178
[DOI] 10.3928/24748307-20210524-02.
[PMID] 34260317.
2017
Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
Journal of the American Pharmacists Association : JAPhA.
57(3):375-381
[DOI] 10.1016/j.japh.2017.03.012.
[PMID] 28506398.
2015
Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
Journal of managed care & specialty pharmacy.
21(12):1124-32
[DOI] 10.18553/jmcp.2015.21.12.1124.
[PMID] 26679962.
2015
Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Journal of managed care & specialty pharmacy.
21(5):401-7
[DOI] 10.18553/jmcp.2015.21.5.401.
[PMID] 25943001.
2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
Journal of managed care & specialty pharmacy.
21(10):956-64
[DOI] 10.18553/jmcp.2015.21.10.956.
[PMID] 26402394.
2015
Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.
24(5):1223-33
[DOI] 10.1007/s11136-014-0842-1.
[PMID] 25432884.
2015
Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Journal of managed care & specialty pharmacy.
21(6):507-14
[DOI] 10.18553/jmcp.2015.21.6.507.
[PMID] 26011552.
2014
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Journal of managed care & specialty pharmacy.
20(8):862-76
[DOI] 10.18553/jmcp.2014.20.8.862.
[PMID] 25062080.
2014
Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
CNS drugs.
28(11):1047-58
[DOI] 10.1007/s40263-014-0191-1.
[PMID] 25086640.
2014
Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Journal of managed care & specialty pharmacy.
20(9):914-9
[DOI] 10.18553/jmcp.2014.20.9.914.
[PMID] 25166290.
2014
Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
Journal of managed care & specialty pharmacy.
20(7):657-67
[DOI] 10.18553/jmcp.2014.20.7.657.
[PMID] 24967519.
2014
Trends and issues in oncology costs.
Expert review of pharmacoeconomics & outcomes research.
14(1):35-44
[DOI] 10.1586/14737167.2014.864561.
[PMID] 24328809.
2013
Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events.
Journal of pain & palliative care pharmacotherapy.
27(3):206-13
[DOI] 10.3109/15360288.2013.803511.
[PMID] 23879214.
2013
Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients.
Journal of managed care pharmacy : JMCP.
19(6):468-77
[DOI] 10.18553/jmcp.2013.19.6.468.
[PMID] 23806061.
2013
Pharmacoeconomics education in US colleges and schools of pharmacy.
American journal of pharmaceutical education.
77(7)
[DOI] 10.5688/ajpe777145.
[PMID] 24052648.
2013
The authors’ reply to Gow et al.: “the state of health economic research in South Africa”.
PharmacoEconomics.
31(3):255-6
[DOI] 10.1007/s40273-013-0027-8.
[PMID] 23430608.
2012
A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Clinical therapeutics.
34(3):605-13
[DOI] 10.1016/j.clinthera.2012.02.007.
[PMID] 22386828.
2012
Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Clinical therapeutics.
34(3):712-9
[DOI] 10.1016/j.clinthera.2012.01.028.
[PMID] 22381712.
2012
Assessing the quality of pharmacoeconomic studies in India: a systematic review.
PharmacoEconomics.
30(9):749-62
[DOI] 10.2165/11590140-000000000-00000.
[PMID] 22720697.
2012
Cost-effectiveness of expanded newborn screening in Texas.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
15(5):613-21
[DOI] 10.1016/j.jval.2012.02.007.
[PMID] 22867769.
2012
Effect of social influences on pharmacists’ intention to report adverse drug events.
Journal of the American Pharmacists Association : JAPhA.
52(5):622-9
[PMID] 23023842.
2012
Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis.
The Annals of pharmacotherapy.
46(11):1453-69
[DOI] 10.1345/aph.1R041.
[PMID] 23136353.
2012
Evaluation of health care costs and utilization patterns for patients with gout.
Clinical therapeutics.
34(3):640-52
[DOI] 10.1016/j.clinthera.2012.01.020.
[PMID] 22381710.
2012
Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Arthritis care & research.
64(9):1423-9
[DOI] 10.1002/acr.21696.
[PMID] 22508663.
2012
Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.
Schizophrenia research.
137(1-3):137-40
[DOI] 10.1016/j.schres.2012.01.043.
[PMID] 22364675.
2012
Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA.
52(5):e109-12
[PMID] 23023857.
2012
Review of survey articles regarding medication therapy management (MTM) services/programs in the United States.
Journal of pharmacy practice.
25(4):457-70
[PMID] 22544620.
2012
The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services.
Clinical therapeutics.
34(11):2196-9
[DOI] 10.1016/j.clinthera.2012.10.002.
[PMID] 23149006.
2012
The state of health economic research in South Africa: a systematic review.
PharmacoEconomics.
30(10):925-40
[DOI] 10.2165/11589450-000000000-00000.
[PMID] 22809450.
2012
Use of antidepressant agents and the risk of type 2 diabetes.
European journal of clinical pharmacology.
68(9):1295-302
[DOI] 10.1007/s00228-011-1168-3.
[PMID] 22120432.
2012
Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.
International journal of clinical pharmacy.
34(3):432-8
[DOI] 10.1007/s11096-012-9608-4.
[PMID] 22249783.
2011
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
14(8):1002-9
[DOI] 10.1016/j.jval.2011.05.043.
[PMID] 22152168.
2011
Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Research in social & administrative pharmacy : RSAP.
7(4):369-82
[DOI] 10.1016/j.sapharm.2010.09.001.
[PMID] 21272531.
2011
Influence of attitudes on pharmacists’ intention to report serious adverse drug events to the Food and Drug Administration.
British journal of clinical pharmacology.
72(1):143-52
[DOI] 10.1111/j.1365-2125.2011.03944.x.
[PMID] 21332572.
2011
Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system.
Clinical therapeutics.
33(5):598-607
[DOI] 10.1016/j.clinthera.2011.04.021.
[PMID] 21665044.
2011
Texas pharmacists’ knowledge of reporting serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA.
51(3):397-403
[DOI] 10.1331/JAPhA.2011.10079.
[PMID] 21555292.
2010
Switching of antiepileptic drug formulations.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
15(2):64-5
[PMID] 22477795.
2010
The need for oral antidiabetic treatment adherence studies in the pediatric population.
Clinical therapeutics.
32(7):1306-7
[DOI] 10.1016/j.clinthera.2010.07.009.
[PMID] 20678678.
2010
The state of health economic evaluation research in Nigeria: a systematic review.
PharmacoEconomics.
28(7):539-53
[DOI] 10.2165/11536170-000000000-00000.
[PMID] 20550221.
2009
Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers.
Administration and policy in mental health.
36(4):278-87
[DOI] 10.1007/s10488-009-0220-4.
[PMID] 19350379.
2009
The need for validation studies of comorbidity adjustment instruments.
Clinical therapeutics.
31(7):1578-80
[DOI] 10.1016/j.clinthera.2009.07.013.
[PMID] 19695407.
2008
Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
Clinical therapeutics.
30 Spec No:1051-7
[DOI] 10.1016/j.clinthera.2008.06.001.
[PMID] 18640479.
2008
Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
The Annals of pharmacotherapy.
42(9):1229-38
[DOI] 10.1345/aph.1L155.
[PMID] 18682544.
2008
Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers’ perspective.
Administration and policy in mental health.
35(3):181-8
[PMID] 18064560.
2008
Pharmacoeconomic education in US colleges and schools of pharmacy: an update.
American journal of pharmaceutical education.
72(3)
[PMID] 18698384.
2007
Influences of attitudes on family physicians’ willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Clinical therapeutics.
29 Suppl:2589-602
[DOI] 10.1016/j.clinthera.2007.12.007.
[PMID] 18164924.
2007
Pharmacoepidemiology education in US colleges and schools of pharmacy.
American journal of pharmaceutical education.
71(4)
[PMID] 17786268.
2007
The need for pharmacoeconomic studies of pharmacy services.
Clinical therapeutics.
29(7):1488-90
[PMID] 17825700.
2006
Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program.
Medical care.
44(1):87-90
[PMID] 16365617.
2006
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Drug safety.
29(7):621-32
[PMID] 16808554.
2006
The $64,000 question–what is a quality-adjusted life-year worth?
Clinical therapeutics.
28(7):1042-3
[PMID] 16990082.
2005
A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination.
Clinical therapeutics.
27(3):346-54
[PMID] 15878389.
2005
A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program.
The Journal of asthma : official journal of the Association for the Care of Asthma.
42(6):447-53
[PMID] 16293539.
2005
Trends in the use of typical and atypical antipsychotics in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry.
44(6):548-56
[PMID] 15908837.
2004
Education in pharmacoeconomics: an international multidisciplinary view.
PharmacoEconomics.
22(3):139-47
[PMID] 14871162.
2004
Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
Psychiatric services (Washington, D.C.).
55(2):151-6
[PMID] 14762239.
2004
Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
92(1):40-6
[PMID] 14756463.
2003
Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
The Journal of clinical psychiatry.
64(6):635-9
[PMID] 12823076.
2003
Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
PharmacoEconomics.
21(10):683-97
[PMID] 12828491.
2003
Role of ethnicity in predicting antipsychotic medication adherence.
The Annals of pharmacotherapy.
37(5):625-30
[PMID] 12708934.
2002
Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy.
Journal of the Southern Orthopaedic Association.
11(2):71-9
[PMID] 12741586.
2001
Dealing with skewed data: an example using asthma-related costs of medicaid clients.
Clinical therapeutics.
23(3):481-98
[PMID] 11318082.
2000
Satisfaction with a computerized practitioner order-entry system at two military health care facilities.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
57(23):2188-95
[PMID] 11127698.
1999
A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database.
The Annals of pharmacotherapy.
33(5):548-53
[PMID] 10369615.
1999
Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer.
PharmacoEconomics.
16(1):43-57
[PMID] 10539121.
1999
Fax technology for collecting outcomes data in a computer database.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
56(24):2540-2
[PMID] 10613373.
1999
Meta-analyses of the effectiveness of erythropoietin for end-stage renal disease and cancer.
Clinical therapeutics.
21(9):1443-55; discussion 1427
[PMID] 10509843.
1997
Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Clinical therapeutics.
19(6):1433-45; discussion 1424
[PMID] 9444451.
1996
Benefits of certification for pharmacy specialists.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996).
NS36(2):128-34
[PMID] 8742011.
1996
Evaluation of physician intervention letters.
Medical care.
34(8):760-6
[PMID] 8709658.
1995
Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications.
Clinical therapeutics.
17(4):786-90
[PMID] 8565041.
1995
Effect of an automated, nursing unit-based drug-dispensing device on medication errors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
52(17):1875-9
[PMID] 8528848.
1995
Effects of Medicaid drug utilization review intervention letters.
Clinical therapeutics.
17(3):525-33; discussion 516
[PMID] 7585856.
1995
Promotion of the appropriate use of outpatient drug therapy in the Texas Medicaid Program through retrospective drug use review.
Pharmacy practice management quarterly.
15(2):57-64
[PMID] 10143599.
1994
Documenting the value of pharmacist interventions.
American pharmacy.
NS34(5):50-4
[PMID] 8037120.
1993
Consumers’ evaluation of value-added pharmacy services.
American pharmacy.
NS33(3):48-56
[PMID] 8475848.
1993
Staff pharmacists’ opinions about performance appraisals.
American journal of hospital pharmacy.
50(6):1181-5
[PMID] 8517458.
1993
Use of clozapine in Texas state mental health facilities.
American journal of hospital pharmacy.
50(8):1663-6
[PMID] 8368220.
1992
Survey of formulary system policies and procedures.
American journal of hospital pharmacy.
49(1):100-3
[PMID] 1570847.
1990
Comparison of women pharmacy and nursing students.
American pharmacy.
NS30(6):49-53
[PMID] 2368669.
1989
Evaluation of mobile cart decentralization.
Hospital pharmacy.
24(5):375-6, 378
[PMID] 10293288.
1988
Brief review of the literature on decentralized drug distribution in hospitals.
American journal of hospital pharmacy.
45(3):639-41
[PMID] 3285676.
1988
Pharmacists’ satisfaction with drug product selection legislation.
American pharmacy.
NS28(10):27-32
[PMID] 3195462.
1987
Multidimensional work sampling to evaluate the effects of computerization in an outpatient pharmacy.
American journal of hospital pharmacy.
44(9):2060-7
[PMID] 3674044.
1986
Work measurement in pharmacy research.
American journal of hospital pharmacy.
43(10):2445-52
[PMID] 3538862.
Contact Details
Phones:
- Business:
- (352) 273-6268
Emails:
- Business:
- krascati@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
GAINESVILLE FL 32610